Vasopressin V1a/V2 receptor (dual)

Class

Dual vasopressin V1a/V2-receptor antagonist

The vasopressin V1a and V2 receptors are two distinct G-protein-coupled receptors activated by arginine vasopressin (also called antidiuretic hormone), a peptide released from the posterior pituitary that governs body water balance and vascular tone. V2 receptors, concentrated in the kidney's collecting ducts, promote water reabsorption by triggering insertion of water channels into the cell membrane. V1a receptors, found on vascular smooth muscle and in the heart, mediate vasoconstriction and contribute to cardiac remodeling. In several conditions—including heart failure and states of low blood sodium (hyponatremia)—vasopressin levels rise inappropriately, driving both excessive water retention through V2 and harmful vasoconstriction or increased cardiac workload through V1a. A dual antagonist blocks both receptor subtypes simultaneously, aiming to increase free-water excretion (a process termed aquaresis) while also easing vasoconstriction, an effect a V2-selective agent alone would not achieve. This combined profile is intended to address the fluid-overload and hemodynamic components of these disorders together. The broader biological rationale for targeting this pathway rests on the central role vasopressin plays in fluid homeostasis, making its receptors a logical point of intervention whenever dysregulated water handling or vascular tone contributes to disease.